Kenneth Seier, MS

Research Biostatistician II
Epidemiology & Biostatistics
Directory
Epidemiology
Biostatistics
Health Outcomes
Computational Oncology
Administrative Resources
Career Opportunities
Educational Opportunities
Departmental Newsletter

Kenneth Seier, MS

Research Biostatistician II
Share
Share
Kenneth Seier

Email

[email protected]

Education

Drexel University

Current Research Interest 

Kenneth Seier joined the department of Epidemiology and Biostatistics at Memorial Sloan Kettering in 2016. His main clinical collaborations at MSKCC are with Hepatopancreatobillary (HPB) surgery, Sarcoma, Anesthesiology and Critical care, and Health informatics. His research interests include prediction modeling and validation, survival analysis in the presence of competing risks, clinical trial design, and propensity score analysis methods.

Publications

  1. Chakraborty S, Ecker BL, Seier K, Aveson VG, Balachandran VP, Drebin JA, D’Angelica MI, Kingham TP, Sigel CS, Soares KC, Vakiani E, Wei AC, Chandwani R, Gonen M, Shen R, Jarnagin WR. Genome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve Clinical Cancer Care. Clin Cancer Res. 2021 Nov 1;27(21):5891-5899. doi: 10.1158/1078-0432.CCR-21-1906. Epub 2021 Aug 25. PMID: 34433650; PMCID: PMC8563403.
  2. Echeverry G, Polskin L, Tollinche LE, Seier K, Tan KS, McCormick PJ, Fischer GW, Grant FM. ROUTINE USE OF SUGAMMADEX DOES NOT SHORTEN PACU LENGTH OF STAY: A PROSPECTIVE DOUBLE-BLINDED RANDOMIZED CONTROLLED TRIAL. Perioper Care Oper Room Manag. 2021 Sep;24:100199. doi: 10.1016/j.pcorm.2021.100199. Epub 2021 Jul 16. PMID: 34504958; PMCID: PMC8423370.
  3. Jolissaint JS, Soares KC, Seier KP, Kundra R, Gönen M, Shin PJ, Boerner T, Sigel C, Madupuri R, Vakiani E, Cercek A, Harding JJ, Kemeny NE, Connell LC, Balachandran VP, D’Angelica MI, Drebin JA, Kingham TP, Wei AC, Jarnagin WR. Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection. Clin Cancer Res. 2021 Jul 15;27(14):4101-4108. doi: 10.1158/1078-0432.CCR-21-0412. Epub 2021 May 7. PMID: 33963001; PMCID: PMC8282702.
  4. Bartlett EK, Curtin CE, Seier K, Qin LX, Hameed M, Yoon SS, Crago AM, Brennan MF, Singer S. Histologic Subtype Defines the Risk and Kinetics of Recurrence and Death for Primary Extremity/Truncal Liposarcoma. Ann Surg. 2021 Jun 1;273(6):1189-1196. doi: 10.1097/SLA.0000000000003453. PMID: 31283560; PMCID: PMC7561049.
  5. Rosenbaum E, Jonsson P, Seier K, Qin LX, Chi P, Dickson M, Gounder M, Kelly C, Keohan ML, Nacev B, Donoghue MTA, Chiang S, Singer S, Ladanyi M, Antonescu CR, Hensley ML, Movva S, D’Angelo SP, Tap WD. Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway Genes. JCO Precis Oncol. 2020 Nov 6;4:PO.20.00122. doi: 10.1200/PO.20.00122. PMID: 33283135; PMCID: PMC7713532.